Award Winning
The first and only long-lasting, peptide-powered frown line treatment 1-8*
Experience Daxxify®*At least 50% of patients in SAKURA 1 and SAKURA 2 had none or mild frown lines for 24 weeks (6 months) and 23.9 weeks (6 months) or longer, respectively, per both investigator’s and patient’s assessments. 4
From TIME. © 2023 TIME USA LLC. All rights reserved. Used under license.
Our Portfolio
Our expertly curated suite of products and services is incredibly innovative in today’s market and serves an unmet need to both our aesthetic provider partners and their clients.
THE FUTURE
OF AESTHETICS
Please see DAXXIFY ® full Prescribing Information , including Boxed Warning and Medication Guide .
Daxxify®
RHA® 4
Daxxify® & Teoxane RHA® Collection
RHA® 4
RHA® 3
Daxxify®
Daxxify® & RHA Redensity™
Daxxify®
Daxxify®
Resources
Providing a new level of excellence in training, education, marketing, practice development, and more.
JOURNEY
Leading With Market Innovation
Revance Aesthetics is meeting unmet market needs with cutting-edge innovation and first-of-its kind products. Our journey is as unique as we are.
Partnership
Our approach is different and focused on delivering growth opportunities for our aesthetic provider partners. We prioritize your practice and your success every step of the way.
